328 related articles for article (PubMed ID: 17121496)
1. Gout in 2006: the perfect storm.
Terkeltaub R
Bull NYU Hosp Jt Dis; 2006; 64(1-2):82-6. PubMed ID: 17121496
[TBL] [Abstract][Full Text] [Related]
2. Crystal ball gazing: new therapeutic targets for hyperuricaemia and gout.
Dalbeth N; Merriman T
Rheumatology (Oxford); 2009 Mar; 48(3):222-6. PubMed ID: 19109320
[TBL] [Abstract][Full Text] [Related]
3. Update on emerging urate-lowering therapies.
Chohan S; Becker MA
Curr Opin Rheumatol; 2009 Mar; 21(2):143-9. PubMed ID: 19339925
[TBL] [Abstract][Full Text] [Related]
4. Novel uricosurics.
Bardin T; Richette P
Rheumatology (Oxford); 2018 Jan; 57(suppl_1):i42-i46. PubMed ID: 29272511
[TBL] [Abstract][Full Text] [Related]
5. [Hyperuricemia and gout: therapeutic indications].
Pawlotsky Y
Rev Prat; 1994 Jan; 44(2):206-9. PubMed ID: 8178077
[TBL] [Abstract][Full Text] [Related]
6. Hyperuricemia and gout: new insights into pathogenesis and treatment.
Pillinger MH; Rosenthal P; Abeles AM
Bull NYU Hosp Jt Dis; 2007; 65(3):215-21. PubMed ID: 17922673
[TBL] [Abstract][Full Text] [Related]
7. Gout and hyperuricemia.
Chilappa CS; Aronow WS; Shapiro D; Sperber K; Patel U; Ash JY
Compr Ther; 2010; 36():3-13. PubMed ID: 21229813
[TBL] [Abstract][Full Text] [Related]
8. The year in gout - 2010-2011.
Crittenden DB; Pillinger MH
Bull NYU Hosp Jt Dis; 2011; 69(3):257-63. PubMed ID: 22035440
[TBL] [Abstract][Full Text] [Related]
9. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
[TBL] [Abstract][Full Text] [Related]
10. New therapies for gout.
Crittenden DB; Pillinger MH
Annu Rev Med; 2013; 64():325-37. PubMed ID: 23327525
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and management of gout.
Pittman JR; Bross MH
Am Fam Physician; 1999 Apr; 59(7):1799-806, 1810. PubMed ID: 10208700
[TBL] [Abstract][Full Text] [Related]
12. Emerging therapies in the long-term management of hyperuricaemia and gout.
Stamp LK; O'Donnell JL; Chapman PT
Intern Med J; 2007 Apr; 37(4):258-66. PubMed ID: 17388867
[TBL] [Abstract][Full Text] [Related]
13. New treatments for gout.
Mapa JB; Pillinger MH
Curr Opin Investig Drugs; 2010 May; 11(5):499-506. PubMed ID: 20419595
[TBL] [Abstract][Full Text] [Related]
14. Metabolic diseases: gout.
Falasca GF
Clin Dermatol; 2006; 24(6):498-508. PubMed ID: 17113968
[TBL] [Abstract][Full Text] [Related]
15. New medications in development for the treatment of hyperuricemia of gout.
Diaz-Torné C; Perez-Herrero N; Perez-Ruiz F
Curr Opin Rheumatol; 2015 Mar; 27(2):164-9. PubMed ID: 25603039
[TBL] [Abstract][Full Text] [Related]
16. Gout: an evidence-based review.
Chen LX; Schumacher HR
J Clin Rheumatol; 2008 Oct; 14(5 Suppl):S55-62. PubMed ID: 18830092
[No Abstract] [Full Text] [Related]
17. Gout: an update.
Eggebeen AT
Am Fam Physician; 2007 Sep; 76(6):801-8. PubMed ID: 17910294
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic approaches in the treatment of gout.
Pillinger MH; Mandell BF
Semin Arthritis Rheum; 2020 Jun; 50(3S):S24-S30. PubMed ID: 32620199
[TBL] [Abstract][Full Text] [Related]
19. Allopurinol dosing in renal impairment: walking the tightrope between adequate urate lowering and adverse events.
Dalbeth N; Stamp L
Semin Dial; 2007; 20(5):391-5. PubMed ID: 17897242
[TBL] [Abstract][Full Text] [Related]
20. Novel drug discovery strategies for gout.
Richette P; Garay R
Expert Opin Drug Discov; 2013 Feb; 8(2):183-9. PubMed ID: 23231400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]